<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000204.v1.p1" parentStudy="phs000204.v1.p1" createDate="2009-06-24" modDate="2010-10-29">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Michael Bamshad, MD</td><td>University of Washington, Seattle, WA, USA</td></tr>
		<tr><td>Funding Source</td><td>5R01HL094976</td><td>National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>5R21HG004749</td><td>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>1RC2HG005608</td><td>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>1R01HD048895</td><td>National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Genetic Analysis of Limb Malformation Disorders: Freeman Sheldon Syndrome Exome Sequencing Study (LMD-FSS)</StudyNameEntrez>
	<StudyNameReportPage>Genetic Analysis of Limb Malformation Disorders: Freeman Sheldon Syndrome Exome Sequencing Study (LMD-FSS)</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Exome Sequencing</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The overall goal of this project is to investigate the etiology and pathogenesis of malformations (i.e., birth defects) of the  	limb, concentrating on abnormalities of limb patterning such as limb deficiency/duplications and multiple congenital contractures.</p>  	<p>The exome sequences of four unrelated individuals were obtained by massively parallel DNA sequencing. The three individuals were  	affected with Freeman Sheldon syndrome (OMIM: <a href="http://www.ncbi.nlm.nih.gov/omim/193700">193700</a>).</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Inclusion:</b> Four affected, unrelated individuals with Freeman Sheldon syndrome.</p>  	<p><b>Exclusion:</b> None.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="19684571"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Contracture"/>
		<Disease vocab_source="MESH" vocab_term="Arthrogryposis"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Michael Bamshad, MD</AttName>
			<Institution>University of Washington, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>5R01HL094976</AttName>
			<Institution>National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>5R21HG004749</AttName>
			<Institution>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>1RC2HG005608</AttName>
			<Institution>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>1R01HD048895</AttName>
			<Institution>National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>Freeman Sheldon syndrome (FSS) is a very rare disease with autosomal dominant inheritance.  The selected individuals have a  	known mutation in MYH3, which is the causative gene in &gt;90% of FSS cases. Therefore, as a proof of concept experiment,  	a hypothesis was made that this gene would be identifiable as a gene common to all four individuals with Freeman Sheldon  	syndrome, wherein each individual had one novel, protein-changing variant in the gene when filtered against public SNP  	databases and HapMap exomes.</p>  	<p>One individual from whom exome sequence was obtained did not consent for deposition of the data into dbGaP and is  	excluded from the dataset.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="Freeman Sheldon Syndrome Exome - General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHLBI</DacName>
      <DacFullName>National Heart, Lung, and Blood Institute DAC</DacFullName>
      <DacEmail>nhlbigeneticdata@nhlbi.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>(301) 480-1455</DacFax>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000204.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000204.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000204.v1.p1" FileName="DUC_phs000204_Exome_FreemanSheldon.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Freeman Sheldon Syndrome Exome - General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>There is no data use limitations for this dataset.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
